HEADER TRANSFERASE 01-OCT-08 3EQP TITLE CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTIVATED CDC42 KINASE 1; COMPND 3 CHAIN: B, A; COMPND 4 FRAGMENT: UNP RESIDUES 117-392; COMPND 5 SYNONYM: ACK-1, TYROSINE KINASE NON-RECEPTOR PROTEIN 2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNK2, ACK1; SOURCE 6 EXPRESSION_SYSTEM: INSECT CELLS KEYWDS ACK1, ALTERNATIVE SPLICING, ATP-BINDING, CELL MEMBRANE, KINASE, KEYWDS 2 MAGNESIUM, MEMBRANE, METAL-BINDING, NUCLEOTIDE-BINDING, KEYWDS 3 PHOSPHOPROTEIN, POLYMORPHISM, SH3 DOMAIN, TRANSFERASE, TYROSINE- KEYWDS 4 PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR J.LIU,Z.WANG,N.P.C.WALKER REVDAT 3 27-DEC-23 3EQP 1 REMARK REVDAT 2 02-JUN-09 3EQP 1 JRNL REVDAT 1 02-DEC-08 3EQP 0 JRNL AUTH D.J.KOPECKY,X.HAO,Y.CHEN,J.FU,X.JIAO,J.C.JAEN,M.G.CARDOZO, JRNL AUTH 2 J.LIU,Z.WANG,N.P.WALKER,H.WESCHE,S.LI,E.FARRELLY,S.H.XIAO, JRNL AUTH 3 F.KAYSER JRNL TITL IDENTIFICATION AND OPTIMIZATION OF JRNL TITL 2 N3,N6-DIARYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINES AS A JRNL TITL 3 NOVEL CLASS OF ACK1 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 6352 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18993068 JRNL DOI 10.1016/J.BMCL.2008.10.092 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0044 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 23616 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1223 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1589 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.35 REMARK 3 BIN R VALUE (WORKING SET) : 0.2670 REMARK 3 BIN FREE R VALUE SET COUNT : 80 REMARK 3 BIN FREE R VALUE : 0.3790 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4321 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 87 REMARK 3 SOLVENT ATOMS : 172 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.32000 REMARK 3 B22 (A**2) : 0.57000 REMARK 3 B33 (A**2) : -0.31000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.15000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.562 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.306 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.213 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.686 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.915 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.854 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4520 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6117 ; 1.529 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 534 ; 6.745 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 209 ;35.189 ;23.014 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 776 ;18.964 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;17.746 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 649 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3438 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2679 ; 0.651 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4315 ; 1.208 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1841 ; 1.649 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1802 ; 2.795 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES: REFINED INDIVIDUALLY REMARK 4 REMARK 4 3EQP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000049656. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-04 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23616 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 91.290 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11000 REMARK 200 FOR THE DATA SET : 6.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.48500 REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.55700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -70.99600 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 21.55700 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS B 161 REMARK 465 PRO B 162 REMARK 465 ASP B 163 REMARK 465 VAL B 164 REMARK 465 LEU B 165 REMARK 465 SER B 166 REMARK 465 LYS A 161 REMARK 465 PRO A 162 REMARK 465 ASP A 163 REMARK 465 VAL A 164 REMARK 465 LEU A 165 REMARK 465 SER A 166 REMARK 465 THR A 391 REMARK 465 ASP A 392 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 390 C - N - CA ANGL. DEV. = 21.3 DEGREES REMARK 500 PRO A 390 C - N - CD ANGL. DEV. = -19.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 129 -141.94 -111.67 REMARK 500 ALA B 147 -167.80 61.60 REMARK 500 ARG B 251 -4.13 76.03 REMARK 500 ASP B 252 37.86 -147.11 REMARK 500 ASP B 270 90.21 61.95 REMARK 500 ASP B 359 -61.80 -24.90 REMARK 500 LEU A 129 -147.40 -128.33 REMARK 500 ALA A 147 -168.30 61.69 REMARK 500 GLN A 221 -69.76 -5.16 REMARK 500 ARG A 251 -3.11 79.03 REMARK 500 ASP A 252 41.19 -147.83 REMARK 500 ASP A 270 85.82 49.91 REMARK 500 ALA A 388 36.70 -99.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLN A 389 PRO A 390 48.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T95 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 393 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T95 A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3EQR RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH INHIBITOR T74 DBREF 3EQP B 117 392 UNP Q07912 ACK1_HUMAN 117 392 DBREF 3EQP A 117 392 UNP Q07912 ACK1_HUMAN 117 392 SEQRES 1 B 276 LEU THR CYS LEU ILE GLY GLU LYS ASP LEU ARG LEU LEU SEQRES 2 B 276 GLU LYS LEU GLY ASP GLY SER PHE GLY VAL VAL ARG ARG SEQRES 3 B 276 GLY GLU TRP ASP ALA PRO SER GLY LYS THR VAL SER VAL SEQRES 4 B 276 ALA VAL LYS CYS LEU LYS PRO ASP VAL LEU SER GLN PRO SEQRES 5 B 276 GLU ALA MET ASP ASP PHE ILE ARG GLU VAL ASN ALA MET SEQRES 6 B 276 HIS SER LEU ASP HIS ARG ASN LEU ILE ARG LEU TYR GLY SEQRES 7 B 276 VAL VAL LEU THR PRO PRO MET LYS MET VAL THR GLU LEU SEQRES 8 B 276 ALA PRO LEU GLY SER LEU LEU ASP ARG LEU ARG LYS HIS SEQRES 9 B 276 GLN GLY HIS PHE LEU LEU GLY THR LEU SER ARG TYR ALA SEQRES 10 B 276 VAL GLN VAL ALA GLU GLY MET GLY TYR LEU GLU SER LYS SEQRES 11 B 276 ARG PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN LEU LEU SEQRES 12 B 276 LEU ALA THR ARG ASP LEU VAL LYS ILE GLY ASP PHE GLY SEQRES 13 B 276 LEU MET ARG ALA LEU PRO GLN ASN ASP ASP HIS TYR VAL SEQRES 14 B 276 MET GLN GLU HIS ARG LYS VAL PRO PHE ALA TRP CYS ALA SEQRES 15 B 276 PRO GLU SER LEU LYS THR ARG THR PHE SER HIS ALA SER SEQRES 16 B 276 ASP THR TRP MET PHE GLY VAL THR LEU TRP GLU MET PHE SEQRES 17 B 276 THR TYR GLY GLN GLU PRO TRP ILE GLY LEU ASN GLY SER SEQRES 18 B 276 GLN ILE LEU HIS LYS ILE ASP LYS GLU GLY GLU ARG LEU SEQRES 19 B 276 PRO ARG PRO GLU ASP CYS PRO GLN ASP ILE TYR ASN VAL SEQRES 20 B 276 MET VAL GLN CYS TRP ALA HIS LYS PRO GLU ASP ARG PRO SEQRES 21 B 276 THR PHE VAL ALA LEU ARG ASP PHE LEU LEU GLU ALA GLN SEQRES 22 B 276 PRO THR ASP SEQRES 1 A 276 LEU THR CYS LEU ILE GLY GLU LYS ASP LEU ARG LEU LEU SEQRES 2 A 276 GLU LYS LEU GLY ASP GLY SER PHE GLY VAL VAL ARG ARG SEQRES 3 A 276 GLY GLU TRP ASP ALA PRO SER GLY LYS THR VAL SER VAL SEQRES 4 A 276 ALA VAL LYS CYS LEU LYS PRO ASP VAL LEU SER GLN PRO SEQRES 5 A 276 GLU ALA MET ASP ASP PHE ILE ARG GLU VAL ASN ALA MET SEQRES 6 A 276 HIS SER LEU ASP HIS ARG ASN LEU ILE ARG LEU TYR GLY SEQRES 7 A 276 VAL VAL LEU THR PRO PRO MET LYS MET VAL THR GLU LEU SEQRES 8 A 276 ALA PRO LEU GLY SER LEU LEU ASP ARG LEU ARG LYS HIS SEQRES 9 A 276 GLN GLY HIS PHE LEU LEU GLY THR LEU SER ARG TYR ALA SEQRES 10 A 276 VAL GLN VAL ALA GLU GLY MET GLY TYR LEU GLU SER LYS SEQRES 11 A 276 ARG PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN LEU LEU SEQRES 12 A 276 LEU ALA THR ARG ASP LEU VAL LYS ILE GLY ASP PHE GLY SEQRES 13 A 276 LEU MET ARG ALA LEU PRO GLN ASN ASP ASP HIS TYR VAL SEQRES 14 A 276 MET GLN GLU HIS ARG LYS VAL PRO PHE ALA TRP CYS ALA SEQRES 15 A 276 PRO GLU SER LEU LYS THR ARG THR PHE SER HIS ALA SER SEQRES 16 A 276 ASP THR TRP MET PHE GLY VAL THR LEU TRP GLU MET PHE SEQRES 17 A 276 THR TYR GLY GLN GLU PRO TRP ILE GLY LEU ASN GLY SER SEQRES 18 A 276 GLN ILE LEU HIS LYS ILE ASP LYS GLU GLY GLU ARG LEU SEQRES 19 A 276 PRO ARG PRO GLU ASP CYS PRO GLN ASP ILE TYR ASN VAL SEQRES 20 A 276 MET VAL GLN CYS TRP ALA HIS LYS PRO GLU ASP ARG PRO SEQRES 21 A 276 THR PHE VAL ALA LEU ARG ASP PHE LEU LEU GLU ALA GLN SEQRES 22 A 276 PRO THR ASP HET T95 B 1 43 HET CL B 393 1 HET T95 A 1 43 HETNAM T95 N-(2,6-DIMETHYLPHENYL)-4-(2-ETHOXYPHENOXY)-2-({4-[4-(2- HETNAM 2 T95 HYDROXYETHYL)PIPERAZIN-1-YL]PHENYL}AMINO)PYRIMIDINE-5- HETNAM 3 T95 CARBOXAMIDE HETNAM CL CHLORIDE ION FORMUL 3 T95 2(C33 H38 N6 O4) FORMUL 4 CL CL 1- FORMUL 6 HOH *172(H2 O) HELIX 1 1 GLY B 122 LYS B 124 5 3 HELIX 2 2 GLN B 167 LEU B 184 1 18 HELIX 3 3 SER B 212 ARG B 218 1 7 HELIX 4 4 HIS B 220 PHE B 224 5 5 HELIX 5 5 LEU B 225 LYS B 246 1 22 HELIX 6 6 ALA B 254 ARG B 256 5 3 HELIX 7 7 GLN B 287 LYS B 291 5 5 HELIX 8 8 PRO B 293 CYS B 297 5 5 HELIX 9 9 ALA B 298 ARG B 305 1 8 HELIX 10 10 HIS B 309 THR B 325 1 17 HELIX 11 11 ASN B 335 LYS B 345 1 11 HELIX 12 12 PRO B 357 TRP B 368 1 12 HELIX 13 13 LYS B 371 ARG B 375 5 5 HELIX 14 14 THR B 377 ALA B 388 1 12 HELIX 15 15 GLN A 167 SER A 183 1 17 HELIX 16 16 LEU A 213 GLN A 221 1 9 HELIX 17 17 GLY A 222 PHE A 224 5 3 HELIX 18 18 LEU A 225 LYS A 246 1 22 HELIX 19 19 ALA A 254 ARG A 256 5 3 HELIX 20 20 PRO A 293 CYS A 297 5 5 HELIX 21 21 ALA A 298 ARG A 305 1 8 HELIX 22 22 SER A 308 THR A 325 1 18 HELIX 23 23 ASN A 335 LYS A 345 1 11 HELIX 24 24 PRO A 357 TRP A 368 1 12 HELIX 25 25 LYS A 371 ARG A 375 5 5 HELIX 26 26 THR A 377 ALA A 388 1 12 SHEET 1 A 6 CYS B 119 LEU B 120 0 SHEET 2 A 6 LEU B 192 VAL B 196 1 O TYR B 193 N CYS B 119 SHEET 3 A 6 LYS B 202 GLU B 206 -1 O VAL B 204 N GLY B 194 SHEET 4 A 6 THR B 152 CYS B 159 -1 N ALA B 156 O THR B 205 SHEET 5 A 6 GLY B 138 ASP B 146 -1 N TRP B 145 O VAL B 153 SHEET 6 A 6 LEU B 126 GLY B 135 -1 N LEU B 129 O ARG B 142 SHEET 1 B 2 PHE B 248 ILE B 249 0 SHEET 2 B 2 ARG B 275 ALA B 276 -1 O ARG B 275 N ILE B 249 SHEET 1 C 2 LEU B 258 THR B 262 0 SHEET 2 C 2 LEU B 265 ILE B 268 -1 O LYS B 267 N LEU B 259 SHEET 1 D 2 HIS B 283 VAL B 285 0 SHEET 2 D 2 THR B 306 SER B 308 -1 O PHE B 307 N TYR B 284 SHEET 1 E 6 CYS A 119 LEU A 120 0 SHEET 2 E 6 LEU A 192 VAL A 196 1 O TYR A 193 N CYS A 119 SHEET 3 E 6 LYS A 202 GLU A 206 -1 O VAL A 204 N GLY A 194 SHEET 4 E 6 THR A 152 CYS A 159 -1 N ALA A 156 O THR A 205 SHEET 5 E 6 GLY A 138 ASP A 146 -1 N ARG A 141 O VAL A 157 SHEET 6 E 6 LEU A 126 GLY A 135 -1 N LEU A 132 O VAL A 140 SHEET 1 F 3 GLY A 211 SER A 212 0 SHEET 2 F 3 LEU A 258 THR A 262 -1 O LEU A 260 N GLY A 211 SHEET 3 F 3 LEU A 265 ILE A 268 -1 O LYS A 267 N LEU A 259 SHEET 1 G 2 PHE A 248 ILE A 249 0 SHEET 2 G 2 ARG A 275 ALA A 276 -1 O ARG A 275 N ILE A 249 SHEET 1 H 2 TYR A 284 VAL A 285 0 SHEET 2 H 2 THR A 306 PHE A 307 -1 O PHE A 307 N TYR A 284 CISPEP 1 ALA B 147 PRO B 148 0 5.21 CISPEP 2 PRO B 199 PRO B 200 0 -5.93 CISPEP 3 ALA A 147 PRO A 148 0 1.81 CISPEP 4 PRO A 199 PRO A 200 0 -7.74 SITE 1 AC1 16 ASP A 383 LEU B 132 GLY B 133 VAL B 140 SITE 2 AC1 16 ALA B 156 LYS B 158 GLU B 177 ILE B 190 SITE 3 AC1 16 THR B 205 ALA B 208 GLY B 211 ARG B 256 SITE 4 AC1 16 ASN B 257 LEU B 259 HOH B 398 HOH B 430 SITE 1 AC2 3 ARG B 216 HIS B 220 ARG B 263 SITE 1 AC3 14 LEU A 132 VAL A 140 ALA A 156 LYS A 158 SITE 2 AC3 14 GLU A 177 ILE A 190 THR A 205 ALA A 208 SITE 3 AC3 14 PRO A 209 GLY A 211 ARG A 256 ASN A 257 SITE 4 AC3 14 LEU A 259 HOH A 396 CRYST1 70.996 43.114 92.848 90.00 99.87 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014085 0.000000 0.002450 0.00000 SCALE2 0.000000 0.023195 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010932 0.00000